Timing correction: L3Harris is scheduled to release results after the market closes today, Wednesday, July 29, 2026, followed by its earnings call at 5:00 p.m. ET—not tomorrow. (investors.l3harris.com)
The central question is no longer whether demand is strong. L3Harris has demonstrated exceptional demand across missile defense, space sensing, missionized aircraft and resilient communications.
The issue going into Q2 is whether that demand is converting into:
Q1 set a high bar: organic revenue grew 15%, orders reached $7.8 billion, book-to-bill was 1.4x, backlog hit $40.7 billion and GAAP EPS increased 33%. Management acknowledged some conservatism in its full-year revenue outlook, making Q2 the logical point for a potential guidance adjustment. (investors.l3harris.com)
| Metric | Q2 consensus / company outlook |
|---|---|
| Q2 revenue consensus | Approximately $5.81 billion |
| Q2 GAAP EPS consensus | Approximately $2.80 |
| 2026 revenue guidance | $23.0–$23.5 billion |
| 2026 segment margin guidance | Low-16% range |
| 2026 GAAP EPS guidance | $11.40–$11.60 |
| 2026 free cash flow guidance | $3.0 billion |
The Q2 consensus implies roughly 7% reported revenue growth and 15% GAAP EPS growth against Q2 2025. Consensus can vary by provider, particularly because L3Harris changed its segment structure and transitioned its headline EPS presentation from non-GAAP to GAAP in 2026. (marketbeat.com)
The Street’s approximately $11.54 full-year EPS estimate sits near the midpoint of guidance, suggesting investors are not broadly positioned for a major EPS raise.
Two announcements on July 27 materially strengthened the long-term Missile Solutions story:
Both are expected to be definitized later in 2026. (l3harris.com)
These agreements are strategically significant but were signed after the quarter ended and are not yet definitized contracts. Investors should therefore distinguish between:
Management said after Q1 that approximately $25 billion of potential Munitions Acceleration Council orders was not yet included in backlog. The key question for the call is how much of that opportunity is now covered by agreed commercial frameworks and when it can formally enter orders and backlog.
A strong headline book-to-bill is helpful, but an explicit bridge from the current $40.7 billion backlog toward management’s previously discussed $60–$70 billion potential would matter more.
Space & Mission Systems delivered 24% Q1 growth, driven by classified ISR, missionized aircraft, space and maritime programs. However, Q1 also benefited from a material-procurement milestone and more productive days, making some sequential normalization likely.
The forward demand picture continues to strengthen. On July 13, the Space Force selected L3Harris to produce 18 Accelerated Missile Defense Tranche 3 satellites. L3Harris now says it has more than 70 missile-tracking and defense satellites on order. (l3harris.com)
What matters in Q2:
The risk is that rapid material procurement supports revenue but dilutes margins. Investors should favor operating-income growth over revenue growth achieved through low-margin pass-through content.
CSD grew only 3% in Q1, although its 25.1% margin remained outstanding. Management specifically said the business should accelerate as 2026 progresses.
The Q1 margin also benefited from a favorable legal settlement, so Q2 should provide a cleaner view of underlying profitability.
Key indicators:
L3Harris has begun high-volume VAMPIRE production and continues to expand the system’s interceptor options, but this remains more of a developing growth vector than a major current earnings contributor. (l3harris.com)
Missile Solutions grew 18% in Q1, with a 12.5% margin. Results included a roughly 30–40-basis-point benefit from legacy asset monetization, partly offset by unfavorable estimate-at-completion adjustments.
The new PAC-3 and THAAD frameworks reinforce the long-term volume thesis, but Q2 investors should focus on current execution:
The bull case depends on capacity investment producing repeatable, profitable output—not simply higher capital intensity.
After Q1’s 15% organic growth, management described the revenue guide as carrying some conservatism and suggested July would be the appropriate time to revisit it.
That makes a modest revenue raise plausible if Q2 execution is clean. However, EPS upside may be constrained by:
A constructive outcome could therefore be:
A revenue raise without corresponding operating-income or cash-flow improvement would be lower quality.
Q1 free cash flow was negative $187 million, versus negative $101 million a year earlier, primarily because of working-capital timing. Management reiterated that cash generation would be heavily weighted to the second half.
That seasonality is normal, but the $3 billion target now requires a significant conversion ramp. Q2 should show a clear improvement in:
Full-year capital expenditures were initially expected to be approximately $600 million, while the broader Missile Solutions plan involves billions of dollars of investment through 2028. The economic quality of the multiyear missile contracts will therefore depend heavily on customer funding and milestone structures.
A weak Q2 cash result would not necessarily force a guidance cut, but it would make the second-half target more difficult to underwrite.
Two transaction updates are essential.
L3Harris confidentially filed for an IPO of Missile Solutions, now named AXYV, and previously targeted completion during the second half of 2026. L3Harris expects to retain control and consolidate the business.
Investors need clarity on:
The IPO can unlock value, but only if the stand-alone valuation compensates LHX holders for dilution and added structural complexity.
L3Harris agreed to sell a 60% stake at an $845 million enterprise value while retaining approximately 40%. Closing was targeted for the second half of 2026, after which management intends to update guidance. (l3harris.com)
The timing and earnings dis-synergies from that transaction could affect the second-half outlook.
Using the July 28 close of $305.24, LHX is:
That is not a low absolute multiple, but the stock has already retraced much of its earlier defense-sector rally. The reaction is therefore likely to depend more on guidance, cash conversion and backlog quality than on a small headline EPS beat.
The quarter itself is unlikely to settle the LHX debate. Demand and strategic positioning are already evident. The report needs to demonstrate that L3Harris can convert that demand into funded backlog, clean operating income and cash while simultaneously financing a major capacity expansion and restructuring its portfolio.
The most consequential disclosures will be:
A modest EPS beat with strong answers on those five issues would likely be more valuable than a large headline beat driven by tax, pension or one-time items.